Evaluating the effects of EECP treatment on patients with mild strokes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of Enhanced External Counterpulsation (EECP) on patients who have experienced high-risk non-disabling ischemic cerebrovascular events (HR-NICE). The study employs a randomized, double-blind, controlled design, where participants are assigned to receive either real or sham EECP treatment. The primary outcome measure is the improvement in symptoms as assessed by the Stroke Impact Scale, alongside comprehensive evaluations using multi-model magnetic resonance imaging and genetic testing to understand the underlying neural and peripheral abnormalities. The goal is to provide objective evidence for the efficacy of EECP in preventing further neurological deterioration in these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* In accordance with the diagnostic criteria of Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018
* Patients who have had a clinically significant ischemic stroke for the first time and are currently stable
* Unilateral internal carotid artery or middle cerebral artery was confirmed for the first time as moderate to severe stenosis (≥50%) or occlusion on digital subtraction angiography examination （DSA）.
* Did not receive surgical treatment such as balloon dilation
* National Institute of Health stroke scale (NIHSS) score ≤3
* The clinical data is completed and be able to consistently complete the study
* Age 18-80, education level≥ 6 years and agree to sign informed consent

Exclusion Criteria:

* Progressive stroke
* Diseases with severe damage to other organs
* Moderate to severe aortic insufficiency
* Dissection aneurysm, aortic aneurysm, cerebral aneurysm
* Significant pulmonary hypertension
* Various bleeding disorders, bleeding tendencies, or use of anticoagulants, Prothrombin international normalized ratio （INR） \>2.0
* Active phlebitis, venous embolism, venous thrombosis of lower extremity
* The presence of infection in the body
* Valvular disease, congenital heart disease, cardiomyopathy
* Uncontrolled hypertension (\>170/110mmHg)
* Uncontrolled arrhythmia
* Left heart failure
* Pregnancy
* Patients with cardiac pacemakers
* Patients with arterial clamp after craniocerebral operation
* Patients with metal implants, such as metal joints, shrapnel and orbital foreign bodies
* History of moderate to severe cognitive impairment or psychiatric disorders
* History of malignancy
* moyamoya patients
* Lower extremity arterial thrombosis

Where it's running

• First Affiliated Hospital of Xian Jiaotong University
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Study coordinator: Wanghuan Dun, doctor
• Email: wanghuandun@163.com
• Phone: 0086-18092706568

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Paired VNS: How the Brain and Pupils Respond in Stroke Patients

  This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.

  Recruiting MGH Institute of Health Professions · Boston, Massachusetts · NCT07922200

• NeuroAiD test in mild to moderate ischemic stroke patients

  This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.

  Recruiting Phase 4 EVD Pharmacy and Medical Company Limited · Ho Chi Minh City · NCT07828210

• Using IMPROVE to guide carotid revascularisation decisions

  This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.

  Recruiting Maastricht University Medical Center · Arnhem, Gelderland and 9 other locations · NCT07556887

• High-intensity interval versus moderate continuous exercise for stroke-related muscle loss

  This will test whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MCIT) better helps people 1–6 months after an ischemic stroke who have muscle loss regain muscle mass, strength, walking ability, and quality of life.

  Recruiting Fenerbahce University · Istanbul, Ataşehir · NCT07456956

• Test of adding a very low-dose edoxaban to standard antiplatelet therapy to prevent another stroke in adults 75 and older

  This trial tests whether adding a tiny amount of edoxaban to aspirin or clopidogrel can better prevent a second stroke in people aged 75+ who recently had an ischemic stroke.

  Recruiting Phase 3 Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07454707

• HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke

  We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.

  Recruiting Phase 3 Weifang Medical University · Weifang, China/Shandong Province · NCT07379190

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.